Is intraoperative embolization with n-butyl cyanoacrylate an alternative option in carotid body tumors surgery? A case report

Basit Öğe Kaydı
dc.contributor.authorKatrancioglu, Nurkay
dc.contributor.authorSerhatlioglu, Faruk
dc.contributor.authorKatrancioglu, Ozgur
dc.date.accessioned2024-11-07T13:32:57Z
dc.date.available2024-11-07T13:32:57Z
dc.date.issued2023
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractIntroduction and importance: The risk of intraoperative bleeding is relatively considerable because carotid body tumors (CBT) have rich vascular structures. Aim is to reduce intraoperative bleeding with preoperative embolization. We present a unique technique for the successful surgical removal of a challenging CBT using intraoperative direct percutaneous intratumoral n-butyl cyanoacrylate (n-BCA) embolization in a patient whose preoperative embolization failed and the operation could not be continued due to intraoperative bleeding.Clinical presentation: A 67-year-old female patient presented with 7 cm Shamblin class 3 CBT on her right neck. Due to the failure of the preoperative embolization, bleeding developed during the operation. In the case of Shamblin class 3 CBT, the primary concern was not the volume of bleeding, but the difficulty in seeing the dissection line due to hemorrhage. Intraoperative n-BCA straight embolization totally controlled the bleeding. The CBT was then readily removed.Clinical discussion: Effective management of intraoperative hemorrhage is essential to ensure successful progression of surgical procedures of CBT. Hemorrhage causes complete disappearance of the dissection line, which is already difficult to detect due to adventitia invasion. It is clear that another method is needed when preoperative embolization or covered stenting fails. n-BCA has been used in the endovenous treatment of varicose veins for a long time, but to the best of our knowledge, there is no other case of its use in intraoperative CBT embolization. Conclusion: Direct intraoperative embolization with n-BCA may be an alternative when other techniques are insufficient.
dc.identifier.doi10.1016/j.ijscr.2023.108636
dc.identifier.issn2210-2612
dc.identifier.pmid37598489
dc.identifier.scopus2-s2.0-85168096282
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1016/j.ijscr.2023.108636
dc.identifier.urihttps://hdl.handle.net/11480/15700
dc.identifier.volume110
dc.identifier.wosWOS:001065652000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofInternational Journal of Surgery Case Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectCarotid body tumor
dc.subjectIntraoperative embolization
dc.subjectn-butyl cyanoacrylate
dc.subjectGlomus tumor
dc.titleIs intraoperative embolization with n-butyl cyanoacrylate an alternative option in carotid body tumors surgery? A case report
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu